Humoral theory of transplantation (Q35142603)

6 August 2017

1 reference

title

Humoral theory of transplantation (English)

1 reference

6 August 2017

Paul I Terasaki

1

1 reference

PubMed ID

12780557

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

American Journal of Transplantation

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

665-673

1 reference

6 August 2017

6

1 reference

Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Acute rejection and the flow cytometry crossmatch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Sensitization and sensitivity: defining the unsensitized patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

A large, single center investigation of the immunogenetic factors affecting liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Susceptibility of liver allografts to high or low concentrations of preformed antibodies as measured by flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Is presensitization relevant to liver transplantation outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Acute humoral renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Tortuosity of the white matter medullary arterioles is related to the severity of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Immunologic monitoring in lung allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Posttransplant immune monitoring of anti-HLA antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Immunoadsorption of sensitized kidney transplant candidates immediately prior to surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Mycophenolate mofetil decreases antibody production after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Pre-transplant anti-epithelial cell antibodies and graft failure after single lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Flow PRA to detect clinically relevant HLA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Pulmonary Infiltrates Associated with Leukoagglutinin Transfusion Reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Sensitization of renal transplant candidates by cryopreserved cadaveric venous or arterial allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Predictive power of ELISA-detected anti-HLA class I antibodies in pediatric kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

High panel reactive antibody against cross-reactive group antigens as a contraindication to renal allotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Evaluation of anti-human leukocyte antigen allo-immunization in pediatric cadaveric kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Call for revolution: a new approach to describing allograft deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Postoperative production of anti-donor antibody and chronic rejection in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Flow cytometry crossmatch: a sensitive technique for assessment of acute rejection in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

An association between posttransplant antibody production and renal transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Posttransplant donor-specific antibody characterization and kidney graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Management of the highly HLA- sensitized patient. A novel role for intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Kidney graft failure and presensitization against HLA class I and class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Anti-endothelial antibodies and coronary artery disease after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

Some recent work on tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Significance of the positive crossmatch test in kidney transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Hyperacute and acute kidney graft rejection due to antibodies against B cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Hyperacute rejection following lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Slow release salbutamol and Tedral in the treatment of reversible airways obstruction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Capillary deposition of C4d complement fragment and early renal graft loss

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Humoral alloreactivity in recipients of renal allografts as a risk factor for the development of delayed graft function

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Glucocorticoid axis abnormalities related to brain damage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Serotyping for Homotransplantation. XXII, Specificity of Cytotoxic Antibodies Developing after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Humoral Antibodies in Renal Allotransplantation in Man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Association between treatment-resistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Anti-HLA antibodies after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Posttransplant antidonor antibodies and graft rejection. Evaluation by two-color flow cytometry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Pretransplant and posttransplant antibodies in human corneal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation. Fluorescence-activated cell sorter analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Mycophenolate mofetil suppresses the production of anti-blood type anitbodies after renal transplantation across the abo blood barrier: ELISA to detect humoral activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

The role of IgA anti-HLA class I antibodies in kidney transplant survival.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

In vitro studies to explain high renal allograft survival in IgA nephropathy patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Association of anti-F(ab')2 antibodies with higher kidney transplant survival rates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Antiidiotypic antibodies to human major histocompatibility complex class I and II antibodies in hepatic transplantation and their role in allograft survival

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Immunomodulation of kidney and heart transplants by anti-idiotypic antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00135.X

7 January 2021

10.1034/J.1600-6143.2003.00135.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12780557